Session Information
AABB Audioconference Series 2011
Click here to go to the previous page
The Science of Hematopoietic Cell Donor Recruitment, Selection and Management
Track
:
Cellular Therapy
Program Code:
114646
Date:
Wednesday, January 12, 2011
Time:
2:00 PM to 3:30 PM
EST
DIRECTOR
:
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
MODERATOR
:
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
SPEAKER
(S):
John Miller, MD, PhD
Linda Abress
Description
Wednesday, January 11, 2012
(124690) Improved Clinical Outcomes in HCT: A Donor and Patient Perspective*
Developed in Conjunction with the National Marrow Donor Program
Director/Moderator: John Miller, MD, PhD
Speaker: Navneet S. Majhail, MD, MS
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching level: Intermediate
Objectives:
• Explain the current state of donor recruitment to the NMDP registry and how this has affected match rates for donors and their recipients.
• Describe how survival after HCT has changed over time and what donor and patient factors may have led to these changes.
• Review how more efficient systems and processes may affect transplant outcomes now and in the future.
Event Description: Since the first successful allogeneic hematopoietic cell (HC) transplants occurred using unrelated donors in the early 1970's, donor registries have grown to over 15 million HLA typed potential donors and over 12,000 unrelated donor transplants occur annually worldwide. This session will address the question of clinical outcomes of HCT. We continue to grow the number of donors on the NMDP registry and we are performing an ever increasing number of transplants for patients in need, but have we improved donor match rates and patient survival rates over the past several decades? This session will address the donor and patient related factors that impact clinical outcomes for the transplant patient and how donor registries and transplant physicians might continue to improve outcomes of transplantation in years to come.
*Cellular Therapy-focused Audioconference.
(124690) Improved Clinical Outcomes in HCT: A Donor and Patient Perspective*
Developed in Conjunction with the National Marrow Donor Program
Director/Moderator: John Miller, MD, PhD
Speaker: Navneet S. Majhail, MD, MS
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching level: Intermediate
Objectives:
• Explain the current state of donor recruitment to the NMDP registry and how this has affected match rates for donors and their recipients.
• Describe how survival after HCT has changed over time and what donor and patient factors may have led to these changes.
• Review how more efficient systems and processes may affect transplant outcomes now and in the future.
Event Description: Since the first successful allogeneic hematopoietic cell (HC) transplants occurred using unrelated donors in the early 1970's, donor registries have grown to over 15 million HLA typed potential donors and over 12,000 unrelated donor transplants occur annually worldwide. This session will address the question of clinical outcomes of HCT. We continue to grow the number of donors on the NMDP registry and we are performing an ever increasing number of transplants for patients in need, but have we improved donor match rates and patient survival rates over the past several decades? This session will address the donor and patient related factors that impact clinical outcomes for the transplant patient and how donor registries and transplant physicians might continue to improve outcomes of transplantation in years to come.
*Cellular Therapy-focused Audioconference.
- Describe how other non-HLA donor characteristics impact patient survival
- Determine how HLA matching of donors and their recipients impact transplantation outcomes
- Explain how donor availability is key to timely HCT and how donor recruitment methods and donor workup processes may affect donor availability when requested for a particular patient
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.9 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |